These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7170839)

  • 41. [Effect of miskleron (clofibrate) on dimethylhydrazine induction of intestinal tumors in rats].
    Bershteĭn LM; Pozharisskiĭ KM; Dil'man VM
    Biull Eksp Biol Med; 1980 Sep; 90(9):350-2. PubMed ID: 7426739
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of nicotinic acid on serum lipids.
    PARSONS WB
    Am Pract Dig Treat; 1961 Apr; 12():247-8. PubMed ID: 13733027
    [No Abstract]   [Full Text] [Related]  

  • 43. The effect of cyclosporine and methylprednisolone on plasma lipoprotein levels in rats.
    Espino A; Lopez-Miranda J; Blanco-Cerrada J; Zambrana JL; Aumente MA; Paniagua JA; Blanco-Molina A; Jimenez-Pereperez JA; Rodriguez M; Pérez-Jiméz F
    J Lab Clin Med; 1995 Feb; 125(2):222-7. PubMed ID: 7844470
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lipoprotein responses to treatment with lovastatin, gemfibrozil, and nicotinic acid in normolipidemic patients with hypoalphalipoproteinemia.
    Vega GL; Grundy SM
    Arch Intern Med; 1994 Jan; 154(1):73-82. PubMed ID: 8267492
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect of clofibrate therapy on serum lipids and lipoproteins].
    Romics L; Szondy E; Gerö S
    Orv Hetil; 1980 Feb; 121(6):321-3. PubMed ID: 7366989
    [No Abstract]   [Full Text] [Related]  

  • 46. Mechanism of action of niacin.
    Kamanna VS; Kashyap ML
    Am J Cardiol; 2008 Apr; 101(8A):20B-26B. PubMed ID: 18375237
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lipids and lipoproteins in hyperlipidemia type IIa during treatment with different lipid lowering drugs.
    Wechsler JG; Hutt V; Klör HU; Ditschuneit H
    Artery; 1980; 8(6):519-29. PubMed ID: 7259531
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of etofibrate retard, bezafibrate and procetofen.
    Luley C; Schwartzkopff W; Schilling A; Calder D; Scheffler W
    Artery; 1980; 8(2):128-33. PubMed ID: 7458677
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anticholesterolemic effect of 3,4-di(OH)-phenylpropionic amides in high-cholesterol fed rats.
    Kim SJ; Bok SH; Lee S; Kim HJ; Lee MK; Park YB; Choi MS
    Toxicol Appl Pharmacol; 2005 Oct; 208(1):29-36. PubMed ID: 16164959
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of clofibrate withdrawal on peroxisomes in mouse hepatocytes.
    Meijer J; Starkerud C; Afzelius BA
    Eur J Cell Biol; 1993 Apr; 60(2):291-9. PubMed ID: 8330627
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Niacin and lipoprotein(a): facts, uncertainties, and clinical considerations.
    Scanu AM; Bamba R
    Am J Cardiol; 2008 Apr; 101(8A):44B-47B. PubMed ID: 18375241
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypolipidemic 4,5-dihydro-4-oxo-5,5-disubstituted-2-furancarboxylic acids.
    Jirkovsky I; Cayen MN
    J Med Chem; 1982 Oct; 25(10):1154-6. PubMed ID: 7143351
    [No Abstract]   [Full Text] [Related]  

  • 53. [Effects of nicotinic acid on the total level of blood cholesterol and its alpha and beta lipoprotein fractions].
    LAVITOLA G; MANCINI M
    Osp Psichiatr; 1956; 24(2):153-6. PubMed ID: 13388369
    [No Abstract]   [Full Text] [Related]  

  • 54. Clofibrate-induced alterations in serum protein patterns.
    Powanda MC; Henriksen EL; Ayala E; Canonico PG
    Biochem Pharmacol; 1976 Apr; 25(7):785-8. PubMed ID: 938580
    [No Abstract]   [Full Text] [Related]  

  • 55. The effect of nicotinic acid, phenyl-ethyl-acetamide, and a combination of both drugs on hypercholesterolemic dogs and human beings.
    NAVA A; COMESANA F; LOZANO E; FISHLEDER BL; SODI-PALLARES D
    Am Heart J; 1958 Oct; 56(4):598-606. PubMed ID: 13571138
    [No Abstract]   [Full Text] [Related]  

  • 56. Comparative study on the in vivo and in vitro antilipolytic effects of etofibrate, nicotinic acid and clofibrate in the rat.
    Bocos C; Herrera E
    Environ Toxicol Pharmacol; 1996 Dec; 2(4):351-7. PubMed ID: 21781742
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of nicotinic acid on concentration of aortic glycosaminoglycans in rats.
    Varghese ET; Mathew A; Kurup PA
    Indian J Biochem Biophys; 1982 Apr; 19(2):150-1. PubMed ID: 7129510
    [No Abstract]   [Full Text] [Related]  

  • 58. [Letter: Clofibrate and clofibrate-inositolnicotinate].
    Wilke H; Frahm H
    Dtsch Med Wochenschr; 1976 Aug; 101(33):1236. PubMed ID: 947731
    [No Abstract]   [Full Text] [Related]  

  • 59. Effects of drugs on postprandial lipoprotein metabolism.
    Packard CJ
    Proc Nutr Soc; 1997 Jul; 56(2):745-51. PubMed ID: 9264125
    [No Abstract]   [Full Text] [Related]  

  • 60. [Clinical evaluation of antiarteriosclerotic drugs in current use].
    Piro S
    Recenti Prog Med; 1972 Apr; 52(4):386-9. PubMed ID: 5068415
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.